§ Lord Morris of Manchesterasked Her Majesty's Government:
Further to the Written Answer by Lord Hunt of Kings Heath on 19 December 2002 (WA156), whether any patient living in England or Northern Ireland could be affected by the case of the blood donor in Scotland found recently to have vCJD and from whom plasma had been used to manufacture haemophilia treatment by the National Health Service; whether any patient living in Wales could be affected; and what contact there has been between the Department of Health and both the Scottish and Welsh Executives about the case. [HL933]
§ Lord Hunt of Kings HeathThe batches of clotting factor concentrates manufactured by the Scottish National Blood Transfusion Service from the plasma taken from a donor who subsequently developed vCJD were distributed to haemophilia centres in Scotland and Northern Ireland. Patients treated with these products living in Scotland and Northern Ireland have been contacted by their clinicians. A small number of patients who received these implicated products are now living in England. Information has been passed to their local haemophilia centres so that they can be contacted. We are not aware of any cases involving patients living in Wales. There was extensive correspondence on this case between the secretariat of the CJD Incidents Panel and the various Scottish bodies involved.